Neurologic diseases are prevalent in patients undergoing invasive procedures; yet, no
societal guidelines exist as to best practice in management of perioperative medications …

Abuse and misuse of prescription drugs remains an ongoing concern in the USA and
worldwide; thus, all centrally active new drugs must be assessed for abuse and dependence …

BACKGROUND Acute appendicitis (AA) is the most common cause of acute abdomen in
children. Anesthesia significantly influences the surgical treatment of AA in children, making …

Хроническая идиопатическая артериальная гипотензия (МКБ-10-I 95.0)
сопровождается снижением качества жизни и многочисленными жалобами, такими как …

Atropine-induced damage is associated with enzyme and protein alterations. The aim of the
present study was to investigate atropine-induced alterations in testicular expression levels …

Fingolimod (Gilenya®), a sphingosine-1-phosphate receptor agonist, is a new oral drug for
treatment of multiple sclerosis in adults. 1 Fingolimod is known to have a transient negative …

The present invention concerns use of an agent that increases sphingosine-1-phosphate
(S1P) receptor activity, such as S1P, or an S1P receptor agonist, for treatment of alcohol …

Objective Fingolimod (Gilenya) is a new oral drug for treatment of multiple sclerosis in adults
(1). It is known that fingolimod therapy commonly carries adverse reactions such as a …